Urapidil

Generic Name
Urapidil
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C20H29N5O3
CAS Number
34661-75-1
Unique Ingredient Identifier
A78GF17HJS
Background

Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.

Indication

用于治疗高血压；尚可用于良性前列腺增生肥大；注射剂主要用于术中高血压危象。

Associated Conditions
Hypertension, Hypertensive Emergency
Associated Therapies
-
Clinical Trials
Related News

Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage

First Posted Date
2024-10-10
Last Posted Date
2024-10-10
Lead Sponsor
Qianfoshan Hospital
Target Recruit Count
600
Registration Number
NCT06635707

Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial

Phase 3
Completed
Conditions
Stroke, Acute
Cerebrovascular Disorders
Interventions
Drug: urapidil
First Posted Date
2019-01-02
Last Posted Date
2023-12-27
Lead Sponsor
The George Institute for Global Health, China
Target Recruit Count
2425
Registration Number
NCT03790800
Locations
🇨🇳

The George Institute for Global Health, Beijing, Beijing, China

🇨🇳

Shanghai East Hospital, Shanghai, Shanghai, China

🇨🇳

The First Affliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China

and more 1 locations

Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under Surgeries

Not Applicable
Completed
Conditions
General Surgery
Interventions
Drug: Urapidil
Drug: Nicardipine
First Posted Date
2018-04-13
Last Posted Date
2020-08-26
Lead Sponsor
Chinese PLA General Hospital
Target Recruit Count
59
Registration Number
NCT03497351
Locations
🇨🇳

Chinese PLA General Hospital, Beijing, Haidian, China

Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)

First Posted Date
2017-10-03
Last Posted Date
2021-11-08
Lead Sponsor
University of Zurich
Registration Number
NCT03300479
Locations
🇨🇭

University Hospital Zurich, Zurich, Switzerland

Effect of High vs. Low MAP Levels on Clinical Outcomes in Elderly Patients During Noncardiothoracic Surgery

First Posted Date
2016-08-05
Last Posted Date
2016-08-16
Lead Sponsor
Hu Anmin
Target Recruit Count
322
Registration Number
NCT02857153
Locations
🇨🇳

West China Hospital affiliated to Sichuan University, Chengdu, Sichuan, China

🇨🇳

The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China

🇨🇳

Shenzhen People's Hospital, Shenzhen, Guangdong, China

and more 4 locations

The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine

Phase 3
Terminated
Conditions
Hypertension
Preeclampsia
Interventions
Drug: Urapidil
Drug: Nicardipine
First Posted Date
2015-09-23
Last Posted Date
2020-08-25
Lead Sponsor
University Hospital, Strasbourg, France
Target Recruit Count
14
Registration Number
NCT02558023
Locations
🇫🇷

Service d'Anesthésie - CMCO, Schiltigheim, France

🇫🇷

Service d'Anesthésie et de Réanimation Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

First Posted Date
2005-09-26
Last Posted Date
2008-06-26
Lead Sponsor
The George Institute
Target Recruit Count
404
Registration Number
NCT00226096
Locations
🇦🇺

Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

🇦🇺

Royal Melbourne Hospital, Melbourne, Victoria, Australia

and more 16 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy